Abstract
We read with much interest the article “Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention and Management” published by D’Amico et al1 in Clinical Gastroenterology and Hepatology. The article highlights the importance of gastrointestinal symptoms in coronavirus disease 2019 (COVID-19), which are increasingly being recognized. In this article, the authors report that the frequency of diarrhea in COVID-19 could be as high as 50%. They also elaborated on the role of angiotensin-converting enzyme 2 (ACE-2) receptors in severe acute respiratory syndrome–associated coronavirus 2 (SARS-CoV-2)–induced diarrhea.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
